Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) to Issue Dividend of $0.03

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) declared a dividend on Friday, August 30th, NASDAQ reports. Shareholders of record on Monday, September 9th will be paid a dividend of 0.0299 per share on Monday, September 30th. The ex-dividend date of this dividend is Monday, September 9th. This is an increase from Clinuvel Pharmaceuticals’s previous dividend of $0.03.

Clinuvel Pharmaceuticals Price Performance

Shares of OTCMKTS CLVLY opened at $9.43 on Friday. The business’s 50-day simple moving average is $9.74 and its 200-day simple moving average is $9.75. Clinuvel Pharmaceuticals has a 52 week low of $8.42 and a 52 week high of $12.06.

Clinuvel Pharmaceuticals Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).